Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Overdiagnosis in respiratory medicine.

Dobler CC, Glasziou PP.

Respirology. 2019 Jun 17. doi: 10.1111/resp.13623. [Epub ahead of print] Review. No abstract available.

2.

Living well with a chronic respiratory disease.

Dobler CC.

Breathe (Sheff). 2019 Jun;15(2):93-94. doi: 10.1183/20734735.0196-2019.

3.

Treatment of stable chronic obstructive pulmonary disease: protocol for a systematic review and evidence map.

Dobler CC, Farah MH, Morrow AS, Alsawas M, Benkhadra R, Hasan B, Prokop LJ, Wang Z, Murad MH.

BMJ Open. 2019 May 5;9(5):e027935. doi: 10.1136/bmjopen-2018-027935.

4.

Use of the terms "overdiagnosis" and "misdiagnosis" in the COPD literature: a rapid review.

Thomas ET, Glasziou P, Dobler CC.

Breathe (Sheff). 2019 Mar;15(1):e8-e19. doi: 10.1183/20734735.0354-2018.

5.

Prevalence of Disagreement About Appropriateness of Treatment Between ICU Patients/Surrogates and Clinicians.

Wilson ME, Dobler CC, Zubek L, Gajic O, Talmor D, Curtis JR, Hinds RF, Banner-Goodspeed VM, Mueller A, Rickett DM, Elo G, Filipe M, Szucs O, Novotny PJ, Piers RD, Benoit DD.

Chest. 2019 Jun;155(6):1140-1147. doi: 10.1016/j.chest.2019.02.404. Epub 2019 Mar 26.

PMID:
30922949
6.

Overdiagnosis of pulmonary embolism: definition, causes and implications.

Dobler CC.

Breathe (Sheff). 2019 Mar;15(1):46-53. doi: 10.1183/20734735.0339-2018. Review.

7.
8.

Shared Decision Making Rarely Happens for Lung Cancer Screening.

Dobler CC.

JAMA Intern Med. 2019 Jan 1;179(1):122. doi: 10.1001/jamainternmed.2018.6983. No abstract available.

PMID:
30615081
9.

Clinicians' cognitive biases: a potential barrier to implementation of evidence-based clinical practice.

Dobler CC, Morrow AS, Kamath CC.

BMJ Evid Based Med. 2018 Dec 28. pii: bmjebm-2018-111074. doi: 10.1136/bmjebm-2018-111074. [Epub ahead of print] No abstract available.

PMID:
30593455
10.

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD.

Dobler CC.

Breathe (Sheff). 2018 Dec;14(4):333-335. doi: 10.1183/20734735.026418.

11.

Breathe: surgical interventions in pulmonary diseases.

Dobler CC.

Breathe (Sheff). 2018 Dec;14(4):262-263. doi: 10.1183/20734735.031418.

12.

Treatment burden should be included in clinical practice guidelines.

Dobler CC, Harb N, Maguire CA, Armour CL, Coleman C, Murad MH.

BMJ. 2018 Oct 12;363:k4065. doi: 10.1136/bmj.k4065. No abstract available.

PMID:
30314981
13.

Impact of decision aids used during clinical encounters on clinician outcomes and consultation length: a systematic review.

Dobler CC, Sanchez M, Gionfriddo MR, Alvarez-Villalobos NA, Singh Ospina N, Spencer-Bonilla G, Thorsteinsdottir B, Benkhadra R, Erwin PJ, West CP, Brito JP, Murad MH, Montori VM.

BMJ Qual Saf. 2019 Jun;28(6):499-510. doi: 10.1136/bmjqs-2018-008022. Epub 2018 Oct 9. Review.

PMID:
30301874
14.

Practical challenges and solutions to TB control in a lower-middle-income country: experiences from Mongolia.

Dobler CC, Batbayar O, Wright CM.

Breathe (Sheff). 2018 Sep;14(3):180-183. doi: 10.1183/20734735.020218.

15.

Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study.

Kaushik N, Lowbridge C, Scandurra G, Dobler CC.

ERJ Open Res. 2018 Jul 13;4(3). pii: 00008-2018. doi: 10.1183/23120541.00008-2018. eCollection 2018 Jul.

16.

A pulmonologist's guide to understanding network meta-analysis.

Dobler CC, Wilson ME, Murad MH.

Eur Respir J. 2018 Jul 4;52(1). pii: 1800525. doi: 10.1183/13993003.00525-2018. Print 2018 Jul. No abstract available.

PMID:
29973354
17.

Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives.

Dobler CC, Fox GJ, Douglas P, Viney KA, Ahmad Khan F, Temesgen Z, Marais BJ.

Eur Respir J. 2018 Jul 11;52(1). pii: 1800591. doi: 10.1183/13993003.00591-2018. Print 2018 Jul. Review.

PMID:
29794133
18.

Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies.

Abu Dabrh AM, Hill AT, Dobler CC, Asi N, Farah WH, Haydour Q, Wang Z, Benkhadra K, Prokop LJ, Murad MH.

BMJ Evid Based Med. 2018 Jun;23(3):96-103. doi: 10.1136/bmjebm-2018-110893. Epub 2018 Apr 20.

PMID:
29678900
19.

Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment.

Dobler CC, Morgan RL, Falck-Ytter Y, Montori VM, Murad MH.

BMJ Evid Based Med. 2018 Apr;23(2):50-53. doi: 10.1136/bmjebm-2017-110852. Epub 2018 Feb 26.

PMID:
29595129
20.

Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection.

Dobler CC, Bosnic-Anticevich S, Armour CL.

ERJ Open Res. 2018 Mar 23;4(1). pii: 00146-2017. doi: 10.1183/23120541.00146-2017. eCollection 2018 Jan.

21.

Noninvasive Ventilation in Patients With Do-Not-Intubate and Comfort-Measures-Only Orders: A Systematic Review and Meta-Analysis.

Wilson ME, Majzoub AM, Dobler CC, Curtis JR, Nayfeh T, Thorsteinsdottir B, Barwise AK, Tilburt JC, Gajic O, Montori VM, Murad MH.

Crit Care Med. 2018 Aug;46(8):1209-1216. doi: 10.1097/CCM.0000000000003082.

PMID:
29498939
22.

Performance of the LACE index to predict 30-day hospital readmissions in patients with chronic obstructive pulmonary disease.

Hakim MA, Garden FL, Jennings MD, Dobler CC.

Clin Epidemiol. 2017 Dec 27;10:51-59. doi: 10.2147/CLEP.S149574. eCollection 2018.

23.

Quality of Shared Decision Making in Lung Cancer Screening: The Right Process, With the Right Partners, at the Right Time and Place.

Dobler CC, Midthun DE, Montori VM.

Mayo Clin Proc. 2017 Nov;92(11):1612-1616. doi: 10.1016/j.mayocp.2017.08.010. Epub 2017 Nov 1. No abstract available.

PMID:
29101930
24.

Can Shared Decision Making Improve Physician Well-Being and Reduce Burnout?

Dobler CC, West CP, Montori VM.

Cureus. 2017 Aug 27;9(8):e1615. doi: 10.7759/cureus.1615.

25.

Interpreting diagnostic tests with continuous results and no gold standard: a common scenario explained using the tuberculin skin test.

Dobler CC, Murad MH.

Evid Based Med. 2017 Dec;22(6):199-201. doi: 10.1136/ebmed-2017-110825. Epub 2017 Oct 22.

PMID:
29056603
26.

Tuberculin Skin Test Conversions and Occupational Exposure Risk in US Healthcare Workers.

Dobler CC, Farah WH, Alsawas M, Mohammed K, Breeher LE, Murad MH, Molella RG.

Clin Infect Dis. 2018 Feb 10;66(5):706-711. doi: 10.1093/cid/cix861.

PMID:
29028965
27.

Cumulative Incidence and Incidence Rate Ratio for Estimation of Risk of Tuberculosis in Patients With Cancer.

Dobler CC.

Clin Infect Dis. 2017 Oct 15;65(8):1423. doi: 10.1093/cid/cix516. No abstract available.

PMID:
29017251
28.

Shared Decision Making in Immigrant Patients.

Dobler CC, Spencer-Bonilla G, Gionfriddo MR, Brito JP.

Cureus. 2017 Jul 12;9(7):e1461. doi: 10.7759/cureus.1461.

29.

Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis.

Dobler CC, Cheung K, Nguyen J, Martin A.

Eur Respir J. 2017 Aug 24;50(2). pii: 1700157. doi: 10.1183/13993003.00157-2017. Print 2017 Aug.

30.

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers.

Rendell NL, Bekhbat S, Ganbaatar G, Dorjravdan M, Pai M, Dobler CC.

PeerJ. 2017 Jul 14;5:e3567. doi: 10.7717/peerj.3567. eCollection 2017.

31.

Patient-perceived treatment burden of chronic obstructive pulmonary disease.

Harb N, Foster JM, Dobler CC.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 1;12:1641-1652. doi: 10.2147/COPD.S130353. eCollection 2017.

32.

Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis.

Chan IHY, Kaushik N, Dobler CC.

Lancet Infect Dis. 2017 Jul;17(7):770-779. doi: 10.1016/S1473-3099(17)30194-9. Epub 2017 Apr 11. Erratum in: Lancet Infect Dis. 2017 Jun;17(6):576.

PMID:
28410979
33.

Response to: Socio-political prescriptions for latent tuberculosis infection are required to prevent reactivation of tuberculosis.

Fox GJ, Dobler CC, Marais BJ, Denholm JT.

Int J Infect Dis. 2017 May;58:117-118. doi: 10.1016/j.ijid.2017.03.004. Epub 2017 Mar 27.

34.

Unwarranted prescription variations for treatment of latent tuberculosis infection.

Dobler CC.

Lancet Infect Dis. 2017 Feb;17(2):134. doi: 10.1016/S1473-3099(17)30004-X. No abstract available.

PMID:
28134105
35.

Biologic Agents and Tuberculosis.

Dobler CC.

Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.TNMI7-0026-2016. Review.

PMID:
28084208
36.

Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.

Rendell NL, Batjargal N, Jadambaa N, Dobler CC.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1615-1620.

PMID:
27931336
37.

Preventive therapy for latent tuberculosis infection-the promise and the challenges.

Fox GJ, Dobler CC, Marais BJ, Denholm JT.

Int J Infect Dis. 2017 Mar;56:68-76. doi: 10.1016/j.ijid.2016.11.006. Epub 2016 Nov 18. Review.

38.

Screening strategies for active tuberculosis: focus on cost-effectiveness.

Dobler CC.

Clinicoecon Outcomes Res. 2016 Jun 30;8:335-47. doi: 10.2147/CEOR.S92244. eCollection 2016. Review.

39.

Benefit of treatment of latent tuberculosis infection in individual patients.

Dobler CC, Martin A, Marks GB.

Eur Respir J. 2016 May;47(5):1594-5. doi: 10.1183/13993003.00175-2016. No abstract available.

40.

Attitudes towards preventive tuberculosis treatment among hospital staff.

Pathak V, Harrington Z, Dobler CC.

PeerJ. 2016 Feb 25;4:e1738. doi: 10.7717/peerj.1738. eCollection 2016.

41.

Repeat exposure to active tuberculosis and risk of re-infection.

Dobler CC, Chidiac R, Williamson JP, Jelfs PJ.

Med J Aust. 2016 Feb 1;204(2):77-8. No abstract available.

PMID:
26821110
42.

Benefit of treatment of latent tuberculosis infection in individual patients.

Dobler CC, Martin A, Marks GB.

Eur Respir J. 2015 Nov;46(5):1397-406. doi: 10.1183/13993003.00577-2015. Epub 2015 Sep 24.

43.

Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011.

Dobler CC, Korver S, Batbayar O, Nyamdulam B, Oyuntsetseg S, Tsolmon B, Surmaajav B, Bayarjargal B, Marais BJ.

Emerg Infect Dis. 2015 Aug;21(8):1451-4. doi: 10.3201/eid2108.141860.

44.

Epidemiology of Peripheral Lymph Node Tuberculosis and Genotyping of M. tuberculosis Strains: A Case-Control Study.

Khandkar C, Harrington Z, Jelfs PJ, Sintchenko V, Dobler CC.

PLoS One. 2015 Jul 15;10(7):e0132400. doi: 10.1371/journal.pone.0132400. eCollection 2015.

45.

Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness.

Wright CM, Westerkamp L, Korver S, Dobler CC.

BMC Infect Dis. 2015 May 8;15:210. doi: 10.1186/s12879-015-0945-5.

46.

Success of community-based directly observed anti-tuberculosis treatment in Mongolia.

Dobler CC, Korver S, Batbayar O, Oyuntsetseg S, Tsolmon B, Wright C, Solongo B, Marais BJ.

Int J Tuberc Lung Dis. 2015 Jun;19(6):657-62. doi: 10.5588/ijtld.14.0927.

PMID:
25946355
47.

Biological agents and tuberculosis: risk estimates and screening strategies.

Dobler CC.

Int J Rheum Dis. 2015 Mar;18(3):264-7. doi: 10.1111/1756-185X.12672. No abstract available.

PMID:
25923605
48.

Challenges in the use of tests to diagnose tuberculosis infection.

Dobler CC.

N S W Public Health Bull. 2013 Nov;24(2):93. doi: 10.1071/NB13012c. No abstract available.

49.

What patient factors predict physicians' decision not to treat latent tuberculosis infection in tuberculosis contacts?

Dobler CC, Luu Q, Marks GB.

PLoS One. 2013 Sep 30;8(9):e76552. doi: 10.1371/journal.pone.0076552. eCollection 2013.

50.

What do we know about the outcomes of tuberculosis contact investigations in NSW?

Dobler CC.

N S W Public Health Bull. 2013 Jul;24(1):34-7. doi: 10.1071/NB12099.

Supplemental Content

Loading ...
Support Center